Dr. Barbesino is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
15 Parkman St
Boston, MA 02114Phone+1 617-726-7573Fax+1 617-726-5905- Is this information wrong?
Education & Training
- UMass Chan Medical SchoolResidency, Internal Medicine, 2001 - 2004
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1995 - 1998
- University of Cattolica del Sacro CuoreClass of 1988
Certifications & Licensure
- MA State Medical License 2004 - 2024
- FL State Medical License 2015 - 2021
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- Glycemic Trends in Patients with Thyroid Eye Disease Treated with Teprotumumab in 3 Clinical Trials.Terry J Smith, Dustin Cavida, Kate Hsu, Sun Kim, Qianhong Fu, Giuseppe Barbesino, Sara Tullis Wester, Robert J Holt, Rajib K Bhattacharya> ;Ophthalmology. 2024 Jan 20
- 1 citationsThyroglobulin Assay Interferences: Clinical Usefulness of Mass-Spectrometry Methods.Giuseppe Barbesino, Alicia Algeciras-Schimnich, Joshua Bornhorst> ;Journal of the Endocrine Society. 2022 Nov 17
- 14 citationsFuture Projections in Thyroid Eye Disease.Giuseppe Barbesino, Mario Salvi, Suzanne K Freitag> ;The Journal of Clinical Endocrinology and Metabolism. 2022 Aug 8
- Join now to see all
Press Mentions
- The Eyes Have It: The Effects of Thyroid Eye DiseaseJanuary 23rd, 2020
Professional Memberships
- Member
Hospital Affiliations
- Massachusetts General HospitalBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: